bioRxivCancer BiologyPreprint
New peptides against B16F10 interfere in cell cycle of melanoma cells
Abstract
Peptides have fantastic functions, they can act interfering in various cellular mechanisms such as the cell cycle. Furthermore, because of their high specificity, peptides can be used in antitumor therapy against specific targets. In this work we describe the in vitro action of four antitumor peptide against B16F10 melanoma cells, obtained from immunoglobulin genes. As a result, we show that peptides interfered in the cell cycle of B16F10 cells. In conclusion the present article describes a molecule from immunoglobulin with future potential for in vivo therapeutic test.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Novel personalized cancer vaccine platform based on Bacillus Calmette-Guerin
E. Ylosmaki, B. Martins, … V. Cerullo·bioRxiv·Mar 5, 2021
- Antibody landscape of C57BL/6 mice cured of B78 melanoma via immunotherapy
A. Hoefges, S. J. McIlwain, … P. M. Sondel·bioRxiv·Feb 24, 2023
- EGFR-targeted and MMP-activated membranolytic peptides derived from Polybia paulista MP1 kill cancer cells specifically in vitro and reduce tumour growth in vivo
Arindam Pramanik, Andrew Booth, … Thomas A. Hughes·bioRxiv·Oct 7, 2025
- Melanoma Response to Immunotherapy is regulated by B Cell-Derived Extracellular Vesicles
Ala’a Al Hrout, Agshin Balayev, … Richard Chahwan·Science AdvancesPeer-reviewed·Oct 8, 2025
- MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas
L. E. Stopfer, N. Rettko, … F. White·bioRxiv·Jan 10, 2022
- Interfering with MIF-CD74 signalling on macrophages and dendritic cells with a peptide-based approach restores the immune response against metastatic melanoma.
C. R. Figueiredo, R. A. Azevedo, … A. Mielgo·bioRxiv·Jan 16, 2018